Addus HomeCare's rising ROCE and capital employed are positive signs. The stock's past five-year performance suggests investors may be overlooking these promising trends, indicating potential investment opportunities.
The stock is undervalued, presenting a buying opportunity as future growth isn't fully reflected in the price. Consider the company's capital structure and management record before investing.
Insiders' lack of purchases last year may concern investors, but their ownership indicates alignment with investors. The largest recent insider sale matching the current share price could hint at limited growth. However, investment decisions shouldn't rely solely on directors' actions.
Addus HomeCare's rising ROCE and regular business investment make it a worthwhile consideration for investors. Its capacity to boost returns while expanding capital hints at future growth possibilities. Despite recent 27% return to shareholders, the company's growth potential may still be underestimated.
爱德斯股票讨论区
新增数据:2023Q2及Q3
2023前3季度营收增长11.11%,营业利润增长31.4%,净利润增长37.3%。
资产负债率从32.5%提高到33.9%,主要是3季度进行了较大收购,长期借款增加到1.64亿,商誉及其他无形资产增加到7.57亿,是6.84亿净资产的111%,资产非常虚。
前3季度现金流经营净额累计低于投资净额,仍然没有产生股东盈余,季度净资产收益率仅达到2.3%。
通过3个季度的观察,ADUS的增长似乎是靠收购支持,实际并未产生股东盈余,净资产收益率也一直维持在较低的水平,目前看投资价值非常有限,暂时退出观察。
资产负债率在2020年从25.3%直接飙升到42%,主要是进行了较大规模收购,之后逐步回落到32.5%,2023Q1进一步回落到30.3%。应收账款近期有所下降,比例也比较正常。商誉及其他无形资产6.55亿,和6.49亿的净资产相当,资产的含金量很小。长期借款近期一直在下降,目前降到了1.1亿。
5年来现金流经营净额累计低于投资净额,没有产生股东盈余,净资产收益率持续小于8%,投资价值有限。
目前价格91.9,市盈率32.4,市盈率TTM 29.7,相对于长期增速来说折扣很高,但是相对于近期增速来说估值太高,吸引力不大,仅可建些观察仓位👀。
• $博思艾伦咨询公司(BAH.US)$: Goldman Sachs Upgrades to Buy from Neutral - PT $102 (from $83)
• $哈门那(HUM.US)$: UBS Upgrades to Buy from Neutral - PT $520 (from $486)
• $JB亨特运输服务(JBHT.US)$: Deutsche Bank Upgrades to Buy from Hold - PT $230 (from $210)
Downgrades
• $JB亨特运输服务(JBHT.US)$: B.Riley Downgrades to Neutral from Buy - PT $33 (from $62)
• $CACI国际(CACI.US)$: Goldman Sachs Downgrad...
暂无评论